Abvc Biopharma (ABVC) Short-Term Debt repayments (2019 - 2025)
Abvc Biopharma (ABVC) has disclosed Short-Term Debt repayments for 7 consecutive years, with $30119.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Short-Term Debt repayments rose 116.15% year-over-year to $30119.0, compared with a TTM value of -$60920.0 through Dec 2025, up 95.35%, and an annual FY2025 reading of $120400.0, up 313.01% over the prior year.
- Short-Term Debt repayments was $30119.0 for Q4 2025 at Abvc Biopharma, down from $31406.0 in the prior quarter.
- Across five years, Short-Term Debt repayments topped out at $1.0 million in Q1 2023 and bottomed at -$1.2 million in Q4 2023.
- Average Short-Term Debt repayments over 4 years is -$34684.3, with a median of $30119.0 recorded in 2025.
- The sharpest move saw Short-Term Debt repayments plummeted 93.54% in 2021, then soared 116.15% in 2025.
- Year by year, Short-Term Debt repayments stood at $4629.0 in 2021, then crashed by 25731.86% to -$1.2 million in 2023, then surged by 84.28% to -$186482.0 in 2024, then surged by 116.15% to $30119.0 in 2025.
- Business Quant data shows Short-Term Debt repayments for ABVC at $30119.0 in Q4 2025, $31406.0 in Q3 2025, and -$186482.0 in Q4 2024.